Skip to main content
Clinical Trials/ChiCTR2100050941
ChiCTR2100050941Not yet recruitingNot Applicable

改良内镜下 Mayo 评分对溃疡性结肠炎范围和严重程度的评估能力

课题经费或自筹1 site in 1 country150 target enrollmentStarted: October 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
150
Locations
1
Primary Endpoint
改良内镜下梅奥评分

Study Overview

Brief Summary

对内镜下 Mayo 评分进行适当的改进,使其不仅能反应溃疡性结肠炎的程度,也能反应病变范围,并且评估改良内镜下 Mayo 评分与血液生化指标、粪便钙卫蛋白、病理活动、临床活动之间关联性的强弱,利用该评分评估生物制剂(维多丽珠单抗)的治疗效果。

Study Design

Study Type
观察性研究
Primary Purpose
连续入组
Masking
N/a

Eligibility Criteria

Ages
18 to 70 (—)
Sex
All

Inclusion Criteria

  • 1.符合溃疡性结肠炎的诊断标准,经组织病理及结肠镜检查确诊;
  • 2.接受完整的结肠镜检查;

Exclusion Criteria

  • 2.合并肝肾功能不全等内科疾病;
  • 3.孕妇或哺乳期妇女;

Arms & Interventions

连续入组

Outcomes

Primary Outcomes

改良内镜下梅奥评分

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
课题经费或自筹

Study Sites (1)

Loading locations...

Similar Trials